China SXT Pharmaceuticals, Inc. (SXTC) stock
Close on Nov 11, 2026Market cap $2.71MP/E –Yield –
China SXT Pharmaceuticals, Inc. saw revenue fall 34.6% to $1.14M over fiscal 2026. At the latest close the market valued the company at $2.71M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026
Valuation
- Market cap
- $2.71M
- P/E ratio
- –
- Price to sales
- 2.38
- Price to book
- 0.09
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.14M
- Net income
- -$6.21M
- EPS, diluted
- -$9.13
Trading
- Previous close
- $2.88
- Open
- $2.81
- Day's range
- $2.80 – $3.01
- Volume
- 51,457
- Average volume (20 days)
- 20,966,540
- 52-week range
- $0.06 – $8371690.00
- RSI (14 days)
- 28.4
- Volatility (1 year)
- 19186.6%
- Relative volume
- 0.01×
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SXTC | S&P 500 | Difference | SXTC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +1803.2% | -2.4% | +1805.6 pts | ||
| 3 months | -99.2% | -1.2% | −98.0 pts | ||
| Year to date | -100.0% | +12.3% | −112.3 pts | ||
| 1 year | -100.0% | +12.4% | −112.4 pts | ||
| 3 years | -100.0% | +78.8% | −178.8 pts | -99.5% | +21.4% |
| 5 years | -100.0% | +75.2% | −175.2 pts | -98.5% | +11.9% |
Eleven years at a glance
Fiscal years 2016 to 2026, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases China SXT Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About China SXT Pharmaceuticals
Pharmaceutical Preparations
China SXT Pharmaceuticals, Inc. operates as a pharmaceutical company focused on traditional Chinese medicine pieces. Through its operating subsidiaries and variable interest entity, the company engages in the research, development, manufacture, and distribution of regular and advanced traditional Chinese medicine piece products. It also participates in tourism town development projects and related commercial activities. The company primarily markets and distributes its medicinal products to pharmaceutical clinics, hospitals, and commercial customers.
Company profile, executives and historyChina SXT Pharmaceuticals stock: common questions
What is China SXT Pharmaceuticals's stock price?
SXTC closed at $2.83 on Nov 11, 2026, down 1.74% on the day. Over the past 52 weeks it traded between $0.06 and $8371690.00.
What is China SXT Pharmaceuticals's market cap?
China SXT Pharmaceuticals was worth $2.71M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is SXTC's P/E ratio?
China SXT Pharmaceuticals lost money over fiscal 2026 (diluted EPS -$9.13), so it has no meaningful P/E ratio.
How much revenue does China SXT Pharmaceuticals make?
China SXT Pharmaceuticals reported revenue of $1.14M for fiscal 2026, down 34.6% from a year earlier.
Does China SXT Pharmaceuticals pay a dividend?
No. China SXT Pharmaceuticals has not paid a cash dividend over the last twelve months.
How has SXTC stock performed over the past year?
Including dividends, SXTC returned -100.0% over the past year, against +12.4% for the S&P 500.
How many SXTC shares are sold short?
0M shares were sold short at the latest FINRA report, 2.95% of the float, or 1.0 days of average trading volume.
Who are China SXT Pharmaceuticals's competitors?
Companies most similar to China SXT Pharmaceuticals by business, industry and size include CPHI, XTLB, LGVN, SPRC, SXTP.
See a number that looks wrong?